Cerebral Vasospasm
📧 Sign up to get email alerts when something new happens for Cerebral Vasospasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage [Phase 3]
A Phase 3 clinical trial evaluating milrinone infusion for cerebral vasospasm after subarachnoid hemorrhage has completed. The snippet does …
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim Study [NA]
The VasoStim study evaluating cervical spinal cord stimulation for cerebral vasospasm after subarachnoid hemorrhage has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage
The completed trial examined transcriptomic signatures associated with vasospasm after aneurysmal subarachnoid hemorrhage. The work aims to …
-
FDA approval · 2025-10-22FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approves an original ANDA for Nicardipine Hydrochloride as a generic product by Caplin Steriles Limited.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Cervical Sympathetic Block in Patients With Cerebral Vasospasm [NA]
This entry reports a Stanford-sponsored clinical trial evaluating cervical sympathetic block for cerebral vasospasm, currently enrolling by …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage [NA]
Upcoming clinical trial evaluating whether transcutaneous vagal nerve stimulation can influence cerebral vasospasm after aneurysmal subarach…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Investigation of the Role of Inflammatory Markers in the Early Detection of Cerebral Vasospasm, Delayed Cerebral Ischemia, and Meningitis Associated With External Cerebrospinal Fluid Drainage After Non-Traumatic Subarachnoid Hemorrhage - A Prospective Case-Control Study
This prospective case-control study assesses whether inflammatory markers can enable early detection of cerebral vasospasm, delayed cerebral…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers. [NA]
A completed clinical trial evaluating a predictive model based on the kinetics of a biomarker panel to forecast cerebral vasospasm in patien…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
Epigenome-wide DNA methylation profiling is being conducted in patients with aneurysmal subarachnoid hemorrhage to study delayed ischemic ne…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage [NA]
Clinical trial update evaluating sympathetic modulation for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. The study is curren…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: The Intra-arterial Vasospasm Trial [Phase 4]
The Phase 4 intra-arterial vasospasm trial was terminated and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm [Phase 3]
Phase 3 trial of acetaminophen for aneurysmal subarachnoid hemorrhage to inhibit lipid peroxidation and cerebral vasospasm was terminated, w…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
The trial evaluated variability in transcranial Doppler technique in neuro-critical care patients. It has been terminated, and results have …
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
Clinical trial update from Beijing Tiantan Hospital describing a recruiting study on brain–heart injury mechanisms after aneurysmal subarach…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital [NA]
An ongoing clinical trial at Martinique University Hospital investigating the incidence, characteristics, and evolution of cerebral vasospas…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
This is a registry update for NeVa VS evaluating management of cerebral vasospasm in post-subarachnoid hemorrhage patients; the trial is not…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage [NA]
This clinical trial compares lumbar drain versus extraventricular drain to prevent cerebral vasospasm after subarachnoid hemorrhage and is c…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Prevention of Vasospasm in SAH Through CSF Treatment [NA]
A recruiting clinical trial at Medical University Innsbruck investigates preventing cerebral vasospasm after aneurysmal subarachnoid hemorrh…
-
FDA approval · 2024-08-28FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for NYMALIZE (nimodipine) from Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage [NA]
This clinical trial evaluates CT perfusion imaging as a predictor of cerebral vasospasm and delayed cerebral ischemia after subarachnoid hem…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm [Phase 4]
Phase 4 trial evaluating acetazolamide challenge with perfusion to predict cerebral vasospasm following aneurysmal subarachnoid hemorrhage; …
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study) [NA]
Clinical trial update for Vesalio NeVa VS in symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage (VITAL Study); trial co…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Magnesium Treating Subarachnoid Hemorrhage Vasospasm [Phase 2, Phase 3]
A clinical trial investigating magnesium for treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage, spanning Phase 2 and Phas…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial [Phase 1, Phase 2]
A phase 1/2 trial evaluating a soluble epoxide hydrolase inhibitor for subarachnoid hemorrhage with delayed cerebral ischemia has completed …
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage [Phase 2]
Phase 2 trial investigating milrinone added to hyperdynamic therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage; the stu…